Civic Intelligence

Osteosarcoma Collaborative Inc

EIN 82-3882732 • 501(c)3 • Gaithersburg, MD

Pub. 78 Eligible990-N CoverageNTEE G30

Profile

The Osteosarcoma Collaborative mission is to educate and advocate for osteosarcoma patients and their families to fund research leading to new therapeutics for those who have this rare and aggressive cancer to advocate surgeons and pathologists to encourage genetic testing for osteosarcoma patients as a change to the standard of care to advocate for better understanding of surgical options including funding the first ever Osteosarcoma Decision Aid and partner with the medical community to change decades old treatment for osteosarcoma

588 Chestertown StGaithersburg, MD 20878
Siviq Scores

Scores are not available for this record yet.

Balance Sheet

Assets

$176,063

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Net Assets

$176,063

No earlier filing loaded for comparison.

Operations

Revenue

$124,324

No earlier filing loaded for comparison.

Expenses

$50,035

No earlier filing loaded for comparison.

Net Income

$74,289

No earlier filing loaded for comparison.

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$200K$150K$100K$50K$0Assets 2022: $176,063Liabilities 2022: $0Net Assets 2022: $176,0632022

Highlighted filing

2022

Assets$176,063
Liabilities$0
Net Assets$176,063

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$150K$100K$50K$0Revenue 2022: $124,324Expenses 2022: $50,035Net Income 2022: $74,2892022

Highlighted filing

2022

Revenue$124,324
Expenses$50,035
Net Income$74,289

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2022Detailed filing. Detailed filing data is available for this year.$1.76$0.00$1.76$1.24$0.50$0.74
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Dec 1, 2021 to Nov 30, 2022
Signed
Oct 10, 2023
Return Version
2021v4.1
Gross Receipts
$124,324
Mission and Program Overview

Mission

The Osteosarcoma Collaborative mission is to educate and advocate for osteosarcoma patients and their families to fund research leading to new therapeutics for those who have this rare and aggressive cancer to advocate surgeons and pathologists to encourage genetic testing for osteosarcoma patients as a change to the standard of care to advocate for better understanding of surgical options including funding the first ever Osteosarcoma Decision Aid and partner with the medical community to change decades old treatment for osteosarcoma

Program Services

DescriptionGrantsExpenses
In 2022 we gave a grant to the MIB Agents for the semi-annual FACTOR conference bringing together over 300 osteosarcoma patients medical professionals advocates and their families As part of that event we sent a board member and a researcher to preview the Osteosarcoma Decision Aid The Aid is the first of its kind surgery decision aid to benefit patients and their families as they are thrown into making life altering decisions shortly after diagnosis This aid has the potential to help thousands of osteosarcoma patients and the coming years and has already benefited many Additionally we were a sponsor for the Pediatric Surgical Oncology Research Group for their annual conference where one of our members spoke to the conference regarding thoracic surgery Osteosarcoma lung mets are the largest reason for lung surgery on young people Finally we updated our website to add more resources on osteosarcoma clinical trials tumor genomics lists of patient support organizations and more$42,814$7,221
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Miriam CohenPresidentPT$0--
Ben MoodyVice-Chairperson-$0--
Christiane RobbinsChief Scientific Advisor-$0--
Lauren FeldmanTreasurer-$0--
Theresa BeechFounding Member-$0--
Filing and Contact Details

Filer

Filer Name
Osteosarcoma Collaborative Inc
EIN
82-3882732
Phone
0000000000
Address
588 CHESTERTOWN ST, GAITHERSBURG, MD 20878

Signing Officer

Name
Lauren Feldman
Title
Treasurer
Phone
4846209911
Signed
2023-10-10
Supplemental Narrative

Additional Explanations

Schedule O:

Other Expense: Program Expense $3,877 Travel and Conferences $2,673 Software $323 License and Permits $229 Bank and CC Processing Fees $119 Grants were given to MIB Agents ($25,000) for the 2022 FACTOR Osteosarcoma conference, to University of Indiana ($21,320.50) in the creation of the Osteosarcoma Decision Aid Other Assets - The Osteosarcoma Collaborative has invested in OSTherapies, specifically to be used to make progress in osteosarcoma therapeutics by taking a drug that was used on canines in a successful clinical trial for osteosarcoma, and has received authorization, and is in the final rounds of clinical trials for humans, AOST-2121. Without private funding, this drug trial would not have been possible.

Raw XML Appendix164 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BenefitsPaidToOrForMembersAmt00
IRS990EZ/BooksInCareOfDetail/PersonNm0Lauren Feldman
IRS990EZ/BooksInCareOfDetail/PhoneNum04846209911
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt02124 Fox Creek Road
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Berwyn
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd019312
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt056774
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt031063
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt0124324
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt074289
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt00
IRS990EZ/FiledScheduleAInd0false
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0101774
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0176063
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GainOrLossFromSaleOfAssetsAmt00
IRS990EZ/GamingGrossIncomeAmt00
IRS990EZ/GrantsAndSimilarAmountsPaidAmt042814
IRS990EZ/GrossProfitLossSlsOfInvntryAmt00
IRS990EZ/GrossReceiptsAmt0124324
IRS990EZ/GrossSalesOfInventoryAmt00
IRS990EZ/InitialReturnInd0X
IRS990EZ/InvestmentIncomeAmt00
IRS990EZ/LandAndBuildingsGrp/BOYAmt00
IRS990EZ/LandAndBuildingsGrp/EOYAmt00
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MembershipDuesAmt00
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0101774
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0176063
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0101774
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0176063
IRS990EZ/OccupancyRentUtltsAndMaintAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt07.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt12.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt22.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt33.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt42.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Miriam Cohen
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Ben Moody
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Christiane Robbins
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Lauren Feldman
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4Theresa Beech
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Vice-Chairperson
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Chief Scientific Advisor
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4Founding Member
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/BOYAmt045000
IRS990EZ/OtherAssetsTotalDetail/EOYAmt0145000
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt07221
IRS990EZ/OtherRevenueTotalAmt00
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0The Osteosarcoma Collaborative mission is to educate and advocate for osteosarcoma patients and their families to fund research leading to new therapeutics for those who have this rare and aggressive cancer to advocate surgeons and pathologists to encourage genetic testing for osteosarcoma patients as a change to the standard of care to advocate for better understanding of surgical options including funding the first ever Osteosarcoma Decision Aid and partner with the medical community to change decades old treatment for osteosarcoma
IRS990EZ/PrintingPublicationsPostageAmt00
IRS990EZ/ProgramServiceRevenueAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0In 2022 we gave a grant to the MIB Agents for the semi-annual FACTOR conference bringing together over 300 osteosarcoma patients medical professionals advocates and their families As part of that event we sent a board member and a researcher to preview the Osteosarcoma Decision Aid The Aid is the first of its kind surgery decision aid to benefit patients and their families as they are thrown into making life altering decisions shortly after diagnosis This aid has the potential to help thousands of osteosarcoma patients and the coming years and has already benefited many Additionally we were a sponsor for the Pediatric Surgical Oncology Research Group for their annual conference where one of our members spoke to the conference regarding thoracic surgery Osteosarcoma lung mets are the largest reason for lung surgery on young people Finally we updated our website to add more resources on osteosarcoma clinical trials tumor genomics lists of patient support organizations and more
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt042814
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt07221
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt00
IRS990EZ/SaleOfAssetsGrossAmt00
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SpecialEventsNetIncomeLossAmt00
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt050035
IRS990EZ/TotalProgramServiceExpensesAmt07221
IRS990EZ/TotalRevenueAmt0124324
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt0124324
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt033544
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt030647
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt059565
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0248080
IRS990ScheduleA/InvestmentIncomeCYPct00
IRS990ScheduleA/InvestmentIncomePYPct00
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00
IRS990ScheduleA/PublicSupportCY509Pct00
IRS990ScheduleA/PublicSupportPY170Pct00
IRS990ScheduleA/PublicSupportPY509Pct00
IRS990ScheduleA/PublicSupportTotal509Amt0248080
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0124324
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt033544
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt030647
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt059565
IRS990ScheduleA/Total509Grp/TotalAmt0248080
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0124324
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt033544
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt030647
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt059565
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt00
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0248080
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Other Expense: Program Expense $3,877 Travel and Conferences $2,673 Software $323 License and Permits $229 Bank and CC Processing Fees $119 Grants were given to MIB Agents ($25,000) for the 2022 FACTOR Osteosarcoma conference, to University of Indiana ($21,320.50) in the creation of the Osteosarcoma Decision Aid Other Assets - The Osteosarcoma Collaborative has invested in OSTherapies, specifically to be used to make progress in osteosarcoma therapeutics by taking a drug that was used on canines in a successful clinical trial for osteosarcoma, and has received authorization, and is in the final rounds of clinical trials for humans, AOST-2121. Without private funding, this drug trial would not have been possible.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Schedule O:
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/PersonNm0Lauren Feldman
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Treasurer
ReturnHeader/BusinessOfficerGrp/PhoneNum04846209911
ReturnHeader/BusinessOfficerGrp/SignatureDt02023-10-10
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0OSTEOSARCOMA COLLABORATIVE INC
ReturnHeader/Filer/BusinessNameControlTxt0OSTE
ReturnHeader/Filer/EIN0823882732
ReturnHeader/Filer/PhoneNum00000000000
ReturnHeader/Filer/USAddress/AddressLine1Txt0588 CHESTERTOWN ST
ReturnHeader/Filer/USAddress/CityNm0GAITHERSBURG
ReturnHeader/Filer/USAddress/StateAbbreviationCd0MD
ReturnHeader/Filer/USAddress/ZIPCd020878
ReturnHeader/ReturnTs02023-10-10T06:26:50Z
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0Lauren
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0Feldman
ReturnHeader/TaxPeriodBeginDt02021-12-01
ReturnHeader/TaxPeriodEndDt02022-11-30
ReturnHeader/TaxYr02021

Document Assets

No mirrored PDF or thumbnail assets are attached yet.